Vaccine shows promising results for early-stage breast cancer patients
(Moffitt Cancer Center) Immunotherapy is a fast growing area of cancer research. It involves developing therapies that use a patient's own immune system to fight and kill cancer. Moffitt Cancer Center is working on a new vaccine that would help early-stage breast cancer patients who have HER2 positive disease.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer Vaccines | HER2 | Immunotherapy | Vaccines